ArticleDiscover oncology2026
Construction of a nomogram for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer based on circulating tumor cells and fibrinogen to albumin ratio.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundOccult peritoneal metastasis (OPM) represents a type of distant metastasis that is often overlooked during the preoperative diagnosis of advanced gastric cancer (AGC).
methodsWe employed the negative enrichment combined with immunofluorescence in situ hybridization (imFISH) technique to detect the number of circulating tumor cells (CTC) in the peripheral blood of patients with AGC. 523 AGC patients were randomly divided into a training set (N = 367) and a validation set (N = 156) in a 7:3 ratio. We constructed a nomogram for predicting OPM risk through multivariate logistic regression. Finally, we evaluated the performance of the nomogram using multi-index cross-validation and clinical decision curve analysis (DCA).
resultsThe number of CTC and the level of the fibrinogen-to-albumin ratio (FAR) in patients with OPM positivity were significantly higher than those in OPM-negative patients. Multivariate logistic regression analysis revealed that CTC > 4/5 mL, FAR > 0.094, CA125 > 35.000 U/mL, and tumor invasion of the serosal layer were identified as independent risk factors for OPM in AGC. The areas under the ROC curve of the nomogram in the training and validation sets were 0.898 and 0.823, respectively. After performing 100 iterations of 10-fold cross-validation, the goodness of fit (R²), area under the curve (AUC), Brier score, and maximum and minimum deviations from the ideal model (Emax and Eavg) all indicated that the nomogram exhibited good performance.
conclusionsThe nomogram developed using CTCs and FAR enhances the early diagnosis of OPM and supports the formulation of personalized treatment plans for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.